Shaobo Ke
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Advanced Glycation End Products research
Papers in
- Co-authors
- Hu Qiu (17 shared papers)Yongshun Chen (15 shared papers)Jiamei Chen (12 shared papers)Wensi Zhao (10 shared papers)Wei Shi (3 shared papers)Yongshun Chen (4 shared papers)Lin Wu (2 shared papers)Yi Gong (2 shared papers)
- Journals
- Radiotherapy and Oncology (3 papers)Journal of Clinical Oncology (1 paper)Gene (1 paper)Cancer Letters (1 paper)Cancer Cell International (1 paper)
- Partner nations
- ChinaNetherlandsJapan
In The Last Decade
Shaobo Ke
24 papers receiving 418 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 78
- Clinical Biochemistry 26
- Oncology 86
- Molecular Biology 177
- Surgery 101
Countries citing papers authored by Shaobo Ke
This map shows the geographic impact of Shaobo Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaobo Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaobo Ke more than expected).
Fields of papers citing papers by Shaobo Ke
This network shows the impact of papers produced by Shaobo Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaobo Ke. The network helps show where Shaobo Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Shaobo Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 80 | |
| 2 | 2014 | 55 | |
| 3 | 2019 | 33 | |
| 4 | 2018 | 28 | |
| 5 | 2016 | 25 | |
| 6 | 2019 | 23 | |
| 7 | 2021 | 21 | |
| 8 | 2023 | 19 | |
| 9 | 2019 | 19 | |
| 10 | 2017 | 17 | |
| 11 | 2018 | 16 | |
| 12 | 2023 | 14 | |
| 13 | 2022 | 13 | |
| 14 | 2021 | 9 | |
| 15 | 2022 | 8 | |
| 16 | 2021 | 8 | |
| 17 | 2018 | 8 | |
| 18 | 2013 | 6 | |
| 19 | Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic. | 2020 | 5 |
| 20 | 2025 | 4 |
About Shaobo Ke
Shaobo Ke is a scholar working on Surgery, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 25 papers that have together received 420 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (8 papers), Gastric Cancer Management and Outcomes (3 papers), Phytochemical compounds biological activities (2 papers), Circular RNAs in diseases (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Mechanisms and Therapy (2 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Cancer Research (78 citations), Clinical Biochemistry (26 citations), Oncology (86 citations), Molecular Biology (177 citations) and Surgery (101 citations). Shaobo Ke has collaborated with scholars based in China, Netherlands and Japan. Frequent co-authors include Hu Qiu, Yongshun Chen, Jiamei Chen, Wensi Zhao, Wei Shi, Yongshun Chen, Lin Wu, Yi Gong, Qiushuang Wang and Wei Shi. Their work appears in journals such as Radiotherapy and Oncology, Journal of Clinical Oncology, Gene, Cancer Letters and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.